Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare</p>
Jyothsna Giri, Ann M. Moyer, Suzette J. Bielinski, et al.
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 305-318
Open Access | Times Cited: 20

Showing 20 citing articles:

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
Arjun P. Athreya, Drew Neavin, Tania Carrillo‐Roa, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 106, Iss. 4, pp. 855-865
Open Access | Times Cited: 94
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
Charlotte Barker, Gabriella Groeneweg, Anke H. Maitland‐van der Zee, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 10, pp. 4297-4310
Open Access | Times Cited: 35
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study)
Fiona FJ Ng, Rashmi Verma, Levana Sani, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 1-2
Open Access
Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
Chonlaphat Sukasem, Thawinee Jantararoungtong, Napatrupron Koomdee
Drug Metabolism and Pharmacokinetics (2021) Vol. 39, pp. 100399-100399
Closed Access | Times Cited: 21
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Pritmohinder S. Gill, Feliciano Yu, Patricia Porter‐Gill, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 5, pp. 394-394
Open Access | Times Cited: 19
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A. Bousman
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 2
Closed Access | Times Cited: 13
One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?
Yudisia Ausi, Melisa Intan Barliana, Maarten J. Postma, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 4863-4874
Open Access | Times Cited: 2
Osteosarcoma, personalized medicine, and tissue engineering; an overview of overlapping fields of research
Azam Bozorgi, Leila Sabouri
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100324-100324
Open Access | Times Cited: 17
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
Paweł Mróz, Stephen Michel, Josiah D. Allen, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations
Christine M. Cheng, Thomas W. So, J Bubp
Annals of Pharmacotherapy (2020) Vol. 55, Iss. 10, pp. 1185-1194
Open Access | Times Cited: 14
Pharmacogenomics and health disparities, are we helping?
Sherin Shaaban, Yuan Ji
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
It is time for educators to act: pharmacogenomics education and its implementation into clinical practice
Snezana Kusljic, Jasmine A. Luzum
Pharmacogenomics (2024), pp. 1-3
Closed Access | Times Cited: 1
Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice
Anastasia Farmaki, Evangelos Manolopoulos, Pantelis Natsiavas
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 9, pp. 442-460
Closed Access
Personalized medicine and pharmacogenomics
Mitar Popović, Marina Jakšić
PONS - medicinski casopis (2024) Vol. 21, Iss. 2, pp. 60-68
Open Access
Antipsychotics Circa 2020: What are we thinking?
Gary Remington, Shitij Kapur
Neuropharmacology (2020) Vol. 175, pp. 108181-108181
Closed Access | Times Cited: 2
Translating Pharmacogenomic Research to Therapeutic Potentials (Bench to Bedside)
Ann M. Moyer, Pedro J. Caraballo
Elsevier eBooks (2021), pp. 220-246
Closed Access | Times Cited: 2
Sikap, Pengetahuan, dan Praktik Mahasiswa Fakultas Kedokteran Universitas YARSI Tentang Farmakogenomik
Farhan Jakaria, Rika Yuliwulandari
Junior Medical Journal (2023) Vol. 2, Iss. 1, pp. 80-90
Open Access
Pharmacogenomics in Cardiovascular Diseases
Adrijana Kekic
Springer eBooks (2023), pp. 201-237
Closed Access
Page 1

Scroll to top